Clinical Trial Update: Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB) [Phase 4]

View source ↗

Summary

Phase 4 crossover trial comparing once-daily fluticasone furoate/vilanterol to twice-daily fluticasone propionate in asthma patients with exercise-induced bronc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fluticasone Furoate/Vilanterol (fluticasone furoate/vilanterol)
• Fluticasone propionate (Fluticasone propionate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 4 | Status: COMPLETED | Results posted: 2017-10-13